Meet the Team
Our group business development team is made up of four individuals who between them have a wide range of complementary skills and experience, working under the leadership of our Business Development Director, Dan Thomas.
Dan Thomas | Chief Corporate Development Officer
Since joining Alliance in 2006 Dan has led Alliance’s M&A and licensing activity, completing over 17 deals. Dan has worked in a variety of roles including senior management in the clinical research (CRO), biotech research and diagnostic sectors as well as in sales operations. Dan has worked in Canada, Germany and France and graduated from Brunel University in Applied Biochemistry. In 2011 Dan won the PLG/AstraZeneca BD Executive of the Year award.
Puja Thapar | Senior Manager, Corporate Development
Puja joined Alliance in May 2013 as Business Development Manager and is involved in growing the Alliance portfolio through acquisitions and licensing deals. Puja graduated with a Biomedical Science degree from the University of Sunderland and has over 12 years of experience in Pharmaceutical industry, 10 years of which have been in Business Development.
Benjamin Holden | Business Insights & Analysis
As Business Insights Analyst, Ben provides commercial analysis and market insights on acquisitions and licensing deals. Ben joined Alliance in April 2016 after graduating with an Honours Degree from the University of Birmingham
Luca Schmidt | Finance Manager, Corporate Development
As Finance Manager Corporate Development, Luca provides valuation, financial modelling and due diligence support on acquisitions and licensing deals. He joined Alliance’s DACH team in May 2016 and moved to the Corporate Development team in Jan 2018. He has a Master's degree in Business Administration with a focus on finance from the University of Düsseldorf in Germany.